Bladder tissue

Bladder tissue refers to the complex anatomical structure of the urinary bladder, a hollow muscular organ in the pelvic cavity designed for the storage and controlled expulsion of urine. It is composed of several specialized layers: the innermost urothelium, which serves as a highly impermeable barrier; the lamina propria; the detrusor smooth muscle; and an outer adventitial layer (StatPearls, 2023). While bladder tissue itself is not a single molecular target, it is the primary site for various pathological conditions, including urothelial carcinoma, interstitial cystitis, and overactive bladder syndrome (NCI, 2024). Pharmacological management of bladder disorders typically involves targeting specific molecular components within the tissue, such as muscarinic acetylcholine receptors or beta-3 adrenergic receptors, to modulate muscle contraction and sensory signaling (Nature Reviews Urology, 2021). Additionally, the bladder's unique accessibility allows for intravesical therapy, where drugs like BCG or chemotherapy are instilled directly into the organ to treat localized malignancy while limiting systemic exposure (PubMed, 2022). Consequently, bladder tissue is a critical focus for urological drug delivery and the identification of diagnostic biomarkers.

Other names

Urinary bladder tissueVesical tissueUrothelial tissueDetrusor tissue

Not applicable as this is an anatomical tissue/organ and not a specific molecular target; however, drugs acting on this tissue typically target muscarinic receptors, beta-3 adrenergic receptors, or involve direct cytotoxic/immunomodulatory effects via intravesical administration.